Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003;20(3):255-60.
doi: 10.1385/JMN:20:3:255.

Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives

Affiliations

Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives

Yanming Wang et al. J Mol Neurosci. 2003.

Abstract

Aseries of novel 2-aryl benzothiazole derivates substituted with iodine in different positions have been synthesized as amyloid-binding ligands. The affinity of these compounds for synthetic amyloid beta (1-40) (Abeta[1-40]) fibrils was determined. Introduction of the iodo group in the position ortho to an amino group increased the binding affinity, whereas the iodination ortho to a hydroxyl group decreased the binding affinity. Selected compounds with high binding affinity and moderate lipophilicity (logP values, 1.65-3.90) were radiolabeled and evaluated in normal mice for brain uptake and clearance. Structure-activity relationship (SAR) studies showed a strong correlation between the lipophilicity of the iodinated compounds and the binding affinity as well as nonspecific binding. As the lipophilicity increased, the affinity for Abeta(1-40) fibrils improved; however, nonspecific binding in mouse brain reflected by low brain clearance also increased with increasing lipophilicity. These results provide important SAR information to guide the development of novel amyloid-binding agents and provide further insights into the molecular interaction between 2-aryl benzothiazole ligands and Abeta fibrils.

PubMed Disclaimer

References

    1. Nat Biotechnol. 2000 Aug;18(8):823-4 - PubMed
    1. J Mol Neurosci. 2002 Aug-Oct;19(1-2):11-6 - PubMed
    1. J Neurosci. 2003 Mar 15;23(6):2086-92 - PubMed
    1. Nat Biotechnol. 2000 Aug;18(8):868-72 - PubMed
    1. Nat Med. 2000 Aug;6(8):916-9 - PubMed

Publication types

MeSH terms